DB18451ExperimentalCell transplant therapies
Col-Treg is an autologous T-cell therapy comprising type I regulatory T-cells specific for human type II collagen.
What you can answer from here — as of April 02, 2025
Which companies are running trials of Col-Treg, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account